Back
Royal Caribbean Group Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
87
RCL
Royal Caribbean Group
Last Price:
225.16
Seasonality Move:
5.55%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Buy
87
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $225.27. The Score for RCL is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $225.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.73 | Buy |
| Relative Strength Index (14 RSI): | 71.9 | Buy |
| Chaikin Money Flow: | 352359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.63 - 213.55) | Buy |
| Bollinger Bands (100): | (152.09 - 191.77) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 225492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.67) | Buy |
| Bollinger Bands (100): | (57.7 - 62.92) | Buy |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 213.05 | Buy |
| 20-day SMA: | 206.15 | Buy |
| 50-day SMA: | 185.5 | Buy |
| 200-day SMA: | 153.26 | Buy |
| 8-day EMA: | 215.37 | Buy |
| 20-day EMA: | 205.89 | Buy |
| 50-day EMA: | 190.47 | Buy |
| 200-day EMA: | 157.06 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.22 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 62.04 | Sell |
| 8-day EMA: | 58.8 | Buy |
| 20-day EMA: | 58.52 | Buy |
| 50-day EMA: | 58.98 | Buy |
| 200-day EMA: | 59.88 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.04 per share, and an increase next year of $2.67 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
Royal Caribbean Group Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||